• News
  • SAN DIEGO
  • Finance

Acadia Pharmaceuticals announces equity financing

Acadia Pharmaceuticals Inc. announced a private placement equity financing and will receive gross proceeds of $86.4 million from the sale of its securities.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Acadia Pharmaceuticals Inc.

Company Website

3911 Sorrento Valley Blvd.
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ACAD
27.04
  0.25  
+ 0.93%
1,039,952,000
32.00
15.64

Insider Trade Data

Date Insider Shares Type Value
09/10/2014 Hacksell, Uli 30,000 Sell $820,821
09/10/2014 Hacksell, Uli 30,000 Exchange $60,000
09/02/2014 Wells, William Mcdowall 30,000 Exchange $40,800
09/02/2014 Kaplan, Lester J 57,692 Sell $1,543,838
09/02/2014 Kaplan, Lester J 57,692 Exchange $75,000

Acadia Pharmaceuticals Inc. Executive(s):

Uli Hacksell

  • Chief Executive Officer, President

Similar Companies

NAICS - 325412 - Pharmaceutical Preparation Manufacturing
SIC - 2834 - PHARMACEUTICAL PREPARATIONS
SIC - 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES
NAICS - 541711 - Research and Development in Biotechnology
SIC - 8731 - COMMERCIAL PHYSICAL AND BIOLOGICAL RESEARCH
SIC - 8733 - NONCOMMERCIAL RESEARCH ORGANIZATIONS
Subscribe Today!